4-Aminosalicylic Acid is a carboxylic or inorganic acid with defined pKₐ value governing its ionisation state across the pH range of biological fluids and pharmaceutical formulations. In pharmaceutical development, 4-Aminosalicylic Acid serves roles including counter-ion selection for API salt formation, pH adjustment and buffering in liquid formulations, and chemical reagent in API synthesis. Toxicological assessment for PDE derivation evaluates local irritancy effects on gastrointestinal mucosa, skin, and respiratory epithelium alongside systemic metabolic consequences of absorbed quantities, with the most sensitive endpoint in the most relevant study forming the POD.
The pharmacologically-based OEL approach is used for 4-Aminosalicylic Acid when its receptor-mediated pharmacodynamic activity in humans produces the most sensitive adverse effect at doses below the NOAEL from general organ toxicity studies.
